IGC Pharma (IGC) Inventory (2011 - 2026)
IGC Pharma (IGC) posted quarterly Inventory of $638000.0 for Q1 2026, down 53.09% year-over-year from $1.4 million in Q1 2025, and little changed quarter-over-quarter from $640000.0 in Q4 2025.
IGC Pharma (IGC) Inventory (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Inventory for 15 consecutive years, with $638000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory fell 53.09% year-over-year to $638000.0; the TTM figure through Mar 2026 stood at $638000.0 (down 53.09% YoY), while the FY2026 annual figure was $638000.0, down 53.09% from the prior year.
- Inventory was little changed at $638000.0 in Q1 2026 per IGC's latest filing, from $640000.0 in the prior quarter.
- Across five years, Inventory topped out at $3.8 million in Q3 2022 and bottomed at $638000.0 in Q1 2026.
- Historically, Inventory has averaged $2.1 million across 5 years, with a median of $1.5 million in 2024.
- On a YoY basis, Inventory climbed as much as 10.66% in 2025 and fell as far as 56.42% in 2025.
- IGC Pharma's Inventory stood at $3.7 million in 2022, then slumped by 48.64% to $1.9 million in 2023, then declined by 25.56% to $1.4 million in 2024, then plunged by 55.34% to $640000.0 in 2025, then declined by 0.31% to $638000.0 in 2026.
- Business Quant data shows IGC's Inventory at $638000.0 in Q1 2026, $640000.0 in Q4 2025, and $658000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 638,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 638,000.00 |
| Dec 31, 2025 | 640,000.00 |
| Sep 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 2.64 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 3.75 Mn |
| Jun 30, 2022 | 3.62 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 5.43 Mn |
| Sep 30, 2021 | 5.50 Mn |
| Jun 30, 2021 | 5.48 Mn |